FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nicholas Duesbery

Research Profile

Chemicals & Drugs

Living Beings

Physiology

Anatomy

Oocytes

Disorders

Concepts & Ideas

Meiosis

Phenomena

Phosphorylation

Co-author Network

Publications

TOP 3
Jennifer L Bromberg-White; Nicholas J Andersen; Nicholas S Duesbery
MEK genomics in development and disease.
Jennifer L Bromberg-White; Daniel Hekman; Eric J Kort; Elissa Boguslawski; Nicholas S Duesbery
Persistent inhibition of oxygen-induced retinal neovascularization by anthrax lethal toxin.
Chih-Shia Lee; Karl J Dykema; Danielle M Hawkins; David M Cherba; Craig Webb; Kyle A Furge; Nicholas S Duesbery
MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nicholas Duesbery (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Jennifer L Bromberg-White; Nicholas J Andersen; Nicholas S Duesbery
MEK genomics in development and disease.
Briefings in functional genomics 2012;11(4):300-10.
2011: Jennifer L Bromberg-White; Daniel Hekman; Eric J Kort; Elissa Boguslawski; Nicholas S Duesbery
Persistent inhibition of oxygen-induced retinal neovascularization by anthrax lethal toxin.
Investigative ophthalmology & visual science 2011;52(12):8979-92.
2011: Chih-Shia Lee; Karl J Dykema; Danielle M Hawkins; David M Cherba; Craig Webb; Kyle A Furge; Nicholas S Duesbery
MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cells.
PloS one 2011;6(2):e17165.
2010: Jennifer Bromberg-White; Chih-Shia Lee; Nicholas S Duesbery
Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxin.
Toxins 2010;2(5):1038-53.
2010: Randall W Alfano; Stephen H Leppla; Shihui Liu; Thomas H Bugge; Janelle M Ortiz; Terry C Lairmore; Nicholas S Duesbery; Ian C Mitchell; Fiemu Nwariaku; Arthur E Frankel
Inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin in an orthotopic model of anaplastic thyroid carcinoma.
Molecular cancer therapeutics 2010;9(1):190-201.
2009: Randall W Alfano; Stephen H Leppla; Shihui Liu; Thomas H Bugge; Cynthia J Meininger; Terry Lairmore; Arlynn F Mulne; Samuel H Davis; Nicholas S Duesbery; Arthur E Frankel
Matrix metalloproteinase-activated anthrax lethal toxin inhibits endothelial invasion and neovasculature formation during in vitro morphogenesis.
Molecular cancer research : MCR 2009;7(4):452-61.
2009: Jennifer L Bromberg-White; Elissa Boguslawski; Nicholas S Duesbery
Perturbation of mouse retinal vascular morphogenesis by anthrax lethal toxin.
PloS one 2009;4(9):e6956.
2009: Arthur E Frankel; Shu-Ru Kuo; David Dostal; Linley Watson; Nicholas S Duesbery; Che-Ping Cheng; Heng-Jie Cheng; Stephen H Leppla
Pathophysiology of anthrax.
Frontiers in bioscience : a journal and virtual library 2009;14():4516-24.
2008: Nicholas S Duesbery; Jeffrey P MacKeigan
Origins of cancer.
Oncogene 2008;27 Suppl 2():S2.
2008: Shu-Ru Kuo; Mark C Willingham; Sarah H Bour; Elissa A Andreas; Seong Kyu Park; Carney Jackson; Nicholas S Duesbery; Stephen H Leppla; Wei-Jen Tang; Arthur E Frankel
Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage.
Microbial pathogenesis 2008;44(6):467-72.
2008: Randall W Alfano; Stephen H Leppla; Shihui Liu; Thomas H Bugge; Meenhard Herlyn; Keiran S Smalley; Jennifer L Bromberg-White; Nicholas S Duesbery; Arthur E Frankel
Cytotoxicity of the matrix metalloproteinase-activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cells.
Molecular cancer therapeutics 2008;7(5):1218-26.
2008: Cecile Rouleau; Krishna Menon; Paula Boutin; Cheryl Guyre; Hitoshi Yoshida; Shiro Kataoka; Michael Perricone; Srinivas Shankara; Arthur E Frankel; Nicholas S Duesbery; George Vande Woude; Hans-Peter Biemann; Beverly A Teicher
The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.
International journal of oncology 2008;32(4):739-48.
2008: Randall W Alfano; Stephen H Leppla; Shihui Liu; Thomas H Bugge; Nicholas S Duesbery; Arthur E Frankel
Potent inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin: implications for broad anti-tumor efficacy.
Cell cycle (Georgetown, Tex.) 2008;7(6):745-9.
2008: Yan Ding; Elissa A Boguslawski; Bree D Berghuis; John J Young; Zhongfa Zhang; Kim Hardy; Kyle A Furge; Eric Kort; Arthur E Frankel; Rick V Hay; James Resau; Nicholas S Duesbery
Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma.
Molecular cancer therapeutics 2008;7(3):648-58.
2008: Jennifer L Bromberg-White; Nicholas S Duesbery
Biological and biochemical characterization of anthrax lethal factor, a proteolytic inhibitor of MEK signaling pathways.
Methods in enzymology 2008;438():355-65.
2008: Dan Huang; Yan Ding; Wang-Mei Luo; Stephanie Bender; Chao-Nan Qian; Eric J Kort; Zhong-Fa Zhang; Kristin VandenBeldt; Nicholas S Duesbery; James Resau; Bin Tean Teh
Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo.
Cancer research 2008;68(1):81-8.
2007: Philippe Depeille; John J Young; Elissa A Boguslawski; Bree Berghuis; Eric J Kort; James Resau; Arthur E Frankel; Nicholas S Duesbery
Anthrax lethal toxin inhibits growth of and vascular endothelial growth factor release from endothelial cells expressing the human herpes virus 8 viral G protein coupled receptor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(19):5926-34.
2007: Bin Tean Teh; Nicholas S Duesbery
A tribute to George F. Vande Woude, a man of character: 2006 Scientific Symposium Winning the War against Cancer: from Genomics to Bedside and Back.
Cancer research 2007;67(6):2394-5.
2007: John J Young; Jennifer L Bromberg-White; Cassandra R Zylstra; Joseph T Church; Elissa Boguslawski; James Resau; Bart Williams; Nicholas S Duesbery
LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin.
PLoS pathogens 2007;3(3):e27.
2007: Philippe Depeille; Y Ding; Jennifer L Bromberg-White; Nicholas S Duesbery
MKK signaling and vascularization.
Oncogene 2007;26(9):1290-6.
2007: Nicholas S Duesbery; Bin Tean Teh
Cancer: biology and therapeutics--a tribute to George Vande Woude.
Oncogene 2007;26(9):1258-9.
2006: Ralph J Abi-Habib; Ravibhushan Singh; Stephen H Leppla; John J Greene; Yan Ding; Bree Berghuis; Nicholas S Duesbery; Arthur E Frankel
Systemic anthrax lethal toxin therapy produces regressions of subcutaneous human melanoma tumors in athymic nude mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7437-43.
2006: Nicholas S Duesbery; George Vande Woude
BRAF and MEK mutations make a late entrance.
Science's STKE : signal transduction knowledge environment 2006;2006(328):pe15.
2006: Jean-François Bodart; Nicholas S Duesbery
Xenopus tropicalis oocytes: more than just a beautiful genome.
Methods in molecular biology (Clifton, N.J.) 2006;322():43-53.
2005: Ralph J Abi-Habib; Jeffrey O Urieto; Shihui Liu; Stephen H Leppla; Nicholas S Duesbery; Arthur E Frankel
BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin.
Molecular cancer therapeutics 2005;4(9):1303-10.
2005: Jean-François Bodart; Frédéric Baert; Chantal Sellier; Nicholas S Duesbery; Stéphane Flament; Jean-Pierre Vilain
Differential roles of p39Mos-Xp42Mpk1 cascade proteins on Raf1 phosphorylation and spindle morphogenesis in Xenopus oocytes.
Developmental biology 2005;283(2):373-83.
2004: Xudong Liang; John J Young; Sherrie A Boone; David S Waugh; Nicholas S Duesbery
Involvement of domain II in toxicity of anthrax lethal factor.
The Journal of biological chemistry 2004;279(50):52473-8.
2003: Eusebio Perdiguero; Marie-Jeanne Pillaire; Jean-François Bodart; Florian Hennersdorf; Morten Frödin; Nicholas S Duesbery; Gema Alonso; Angel R Nebreda
Xp38gamma/SAPK3 promotes meiotic G(2)/M transition in Xenopus oocytes and activates Cdc25C.
The EMBO journal 2003;22(21):5746-56.
2003: Arun P Chopra; Sherrie A Boone; Xudong Liang; Nicholas S Duesbery
Anthrax lethal factor proteolysis and inactivation of MAPK kinase.
The Journal of biological chemistry 2003;278(11):9402-6.
2003: Sung O Kim; Qing Jing; Kasper Hoebe; Bruce Beutler; Nicholas S Duesbery; Jiahuai Han
Sensitizing anthrax lethal toxin-resistant macrophages to lethal toxin-induced killing by tumor necrosis factor-alpha.
The Journal of biological chemistry 2003;278(9):7413-21.
2003: Arthur E Frankel; Han-Mo Koo; Stephen H Leppla; Nicholas S Duesbery; George Vande Woude
Novel protein targeted therapy of metastatic melanoma.
Current pharmaceutical design 2003;9(25):2060-6.
2002: Arthur E Frankel; Bayard L Powell; Nicholas S Duesbery; George Vande Woude; Stephen H Leppla
Anthrax fusion protein therapy of cancer.
Current protein & peptide science 2002;3(4):399-407.
2002: Jean-François Bodart; Davina V Gutierrez; Angel R Nebreda; Bree D Buckner; James Resau; Nicholas S Duesbery
Characterization of MPF and MAPK activities during meiotic maturation of Xenopus tropicalis oocytes.
Developmental biology 2002;245(2):348-61.
2002: Nicholas S Duesbery; George Vande Woude
Developmental biology: an arresting activity.
Nature 2002;416(6883):804-5.
2002: Han-Mo Koo; Matthew W VanBrocklin; Mary Jane McWilliams; Stephen H Leppla; Nicholas S Duesbery; George Vande Woude
Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(5):3052-7.
2002: Jean-François Bodart; A Chopra; X Liang; Nicholas S Duesbery
Anthrax, MEK and cancer.
Cell cycle (Georgetown, Tex.) 2002;1(1):10-5.
2001: Nicholas S Duesbery; James Resau; Craig Webb; S Koochekpour; Han-Mo Koo; Stephen H Leppla; George Vande Woude
Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(7):4089-94.
1999: Nicholas S Duesbery; George Vande Woude
Anthrax toxins.
Cellular and molecular life sciences : CMLS 1999;55(12):1599-609.
1999: Nicholas S Duesbery; George Vande Woude
Anthrax lethal factor causes proteolytic inactivation of mitogen-activated protein kinase kinase.
Journal of applied microbiology 1999;87(2):289-93.
1999: Nicholas S Duesbery; Craig Webb; George Vande Woude
MEK wars, a new front in the battle against cancer.
Nature medicine 1999;5(7):736-7.
1998: Nicholas S Duesbery; George Vande Woude
Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes.
Biology of the cell / under the auspices of the European Cell Biology Organization 1998;90(6-7):461-6.
1998: Nicholas S Duesbery; Craig Webb; Stephen H Leppla; V M Gordon; KR Klimpel; T D Copeland; N G Ahn; MK Oskarsson; K Fukasawa; KD Paull; George Vande Woude
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.
Science (New York, N.Y.) 1998;280(5364):734-7.
1997: Nicholas S Duesbery; T Choi; K D Brown; Kenneth W Wood; James Resau; K Fukasawa; Don W Cleveland; George Vande Woude
CENP-E is an essential kinetochore motor in maturing oocytes and is masked during mos-dependent, cell cycle arrest at metaphase II.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(17):9165-70.
1996: Nicholas S Duesbery; Y Masui
The role of microtubules and inositol triphosphate induced Ca2+ release in the tyrosine phosphorylation of mitogen-activated protein kinase in extracts of Xenopus laevis oocytes.
Zygote (Cambridge, England) 1996;4(1):21-30.
1993: Nicholas S Duesbery; Y Masui
Changes in protein association with intracellular membranes of Xenopus laevis oocytes during maturation and activation.
Zygote (Cambridge, England) 1993;1(2):129-41.